HUM - Humana Inc Stock Analysis

Humana Inc (HUM) is a publicly traded company listed on the NYSE. It operates in the Healthcare Plans industry, part of the broader Healthcare sector. The company has a market capitalization of 32.87B, generates annual revenue of 126.36B, and reports net income of 1.29B. As of the latest data, the stock is trading at 273.28 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (1.38%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.

Analyst recommendation stands at Hold (3.53), indicating current market sentiment. Institutional ownership is reported at 96.41%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -2.22%, trading within a 52-week range of 206.87 - 315.35.

HUM - Humana Inc

273.28
Analyst Consensus
Hold 3.53
HUM – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 6
  • Buy: 6
  • Hold: 19
  • Sell: 1
  • Strong Sell: 0
  • Total Analysts:  32

Last update: 2026-01-20 04:47:22
Index: S&P 500 P/E: 25.61 EPS (ttm): 10.67 Insider Own: 0.25% Shs Outstand: 120.27M Perf Week: -1.29%
Market Cap: 32.87B Forward P/E: 22.65 EPS next Y: 12.07 Insider Trans: 0.00% Shs Float: 119.98M Perf Month: 5.86%
Income(ttm): 1.29B PEG: 3.79 EPS next Q: -4.00 Inst Own: 96.41% Short Float: 4.41% Perf Quarter: 2.24%
Revenue(ttm): 126.36B P/S: 0.26 EPS this Y: 5.38% Inst Trans: 1.29% Short Ratio: 3.77 Perf Half Y: 23.99%
Book/sh: 154.00 P/B: 1.77 EPS next Y: -29.36% ROA: 2.59% Short Interest: 5.30M Perf Year: -2.22%
Cash/sh: - P/C: - EPS next 5Y: 5.97% ROE: 7.15% 52W Range: 206.87 - 315.35 Perf YTD: 6.70%
Dividend Est.: 3.76 (1.38%) P/FCF: 21.25 EPS past 3/5Y: -23.91% -13.05% ROIC: 4.15% 52W High: 315.35 -13.34% Beta: 0.45
Dividend TTM: 3.54 (1.30%) Quick Ratio: - Sales past 3/5Y: 12.09% 12.65% Gross Margin: - 52W Low: 206.87 32.10% Perf 5Y: -36.97%
Dividend Ex-Date: Dec 26, 2025 Current Ratio: 2.02 EPS Y/Y TTM: -5.58% Oper. Margin: 2.35% RSI (14): 55.05 Volatility: 3.25% 2.65%
Employees: 65680 Debt/Eq: 0.68 Sales Y/Y TTM: 9.87% Profit Margin: 1.02% Recom: 2.55 Target Price: 284.96
Option/Short: Yes / Yes LT Debt/Eq: 0.68 EPS Q/Q: -59.37% Payout: 35.45% Rel Volume: 0.63 Prev Close: 283.95
Sales Surprise: 2.04% EPS Surprise: 10.73% Sales Q/Q: 11.06% Earnings: Feb 11 BMO Avg Volume: 1.40M Price: 273.28
SMA20: 2.01% SMA50: 6.98% SMA200: 5.45% Overbought: -4.27%
Volume: 881,793 Change: -3.76%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Humana Inc

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2026 www.stocks-expert.com All Rights Reserved.